Source: Annual Congress 2011 - Mechanical ventilation and lung injury: new advances
Disease area: Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
F. Chertcoff, M. Blasco, C. Giuffre, L. Maldonado, S. Verbanaz, E. Soloaga, E. Descotte, E. Efron (Buenos Aires, Argentina). Efficacy of a ventilator bundle for the prevention of the ventilator-associated pneumonia. Eur Respir J 2011; 38: Suppl. 55, 1989

Member's Comments

No comment yet.

Related content which might interest you: Preventing ventilator-associated pneumonia Source: International Congress 2017 – PG12 Life-threatening pulmonary infections Year: 2017 Bundles for the prevention of ventilator-associated pneumonia in a Brazilian hospital Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015 Evidence on measures for the prevention of ventilator-associated pneumonia Source: Eur Respir J 2007; 30: 1193-1207 Year: 2007 How to prevent ventilator-associated pneumonia Source: Annual Congress 2013 –PG3 Infections and critical patients: emerging problems and clinical strategies Year: 2013 Challenges in the management of hospital-acquired pneumonia including ventilator-associated pneumonia Source: ERS Course 2018 - Respiratory Infections Year: 2018 Optimizing treatment for community-acquired pneumonia through a care bundle Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia Year: 2019 Reducing antibiotics use for ventilator-associated pneumonia in brain-injured patients Source: Eur Respir J 2016; 47: 1060-1061 Year: 2016 Nebulised colistin for ventilator-associated pneumonia prevention Source: Eur Respir J 2015; 46: 1732-1739 Year: 2015 Treatment failure of severe and ventilator-associated pneumonia Source: Annual Congress 2012 - PG17 Clinical failure of treatment of respiratory infections Year: 2012 Diagnosis of ventilator-associated pneumonia Source: Annual Congress 2007 - Pulmonary infections and inflammation Year: 2007 International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia Source: Eur Respir J, 50 (3) 1700582; 10.1183/13993003.00582-2017 Year: 2017 International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia Source: Guideline 2017 Year: 2017 VAP prevention: pharmacological strategies Source: Eur Respir Mon 2011; 53: 74-82 Year: 2011 Cost of treatment failure in community-acquired pneumonia Source: Eur Respir J 2007; 30: Suppl. 51, 195s Year: 2007 Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia Source: Eur Respir J 2011; 37: 1332-1339 Year: 2011 Study of prone positioning to reduce ventilator-associated pneumonia in hypoxaemic patients Source: Eur Respir J 2010; 35: 795-804 Year: 2010 Implications of identifying the pathogen in ventilator-associated pneumonia (VAP) Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013 Pharmacokinetic optimisation of β-lactams for the treatment of ventilator-associated pneumonia Source: Eur Respir Rev 2007; 16: 45-49 Year: 2007 Tracheotomy and ventilator-associated pneumonia: the importance of oral care Source: Eur Respir J 2008; 31: 221 Year: 2008 The association of ventilator-associated pneumonia with the frequent exchange of endotracheal tube Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections Year: 2016